| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 2579277 | Thérapie | 2010 | 8 Pages |
Abstract
An important loss of histaminergic neurons has been observed in AD. In contrast, levels of the histamine metabolite in the CSF of AD patients show that their global activity is decreased by only 25%. This indicates that activating histamine neurons in AD can be envisaged.
Related Topics
Health Sciences
Pharmacology, Toxicology and Pharmaceutical Science
Pharmacology, Toxicology and Pharmaceutics (General)
Authors
Mouhammad Motawaj, Aude Burban, Elisabeth Davenas, Florence Gbahou, Raphaël Faucard, Séverine Morisset, Jean-Michel Arrang,